Dr Arul M Lingappan, MD | |
1935 Medical District Dr, Dallas, TX 75235-7701 | |
(214) 456-6393 | |
(214) 456-5587 |
Full Name | Dr Arul M Lingappan |
---|---|
Gender | Male |
Speciality | Anesthesiology - Pediatric Anesthesiology |
Location | 1935 Medical District Dr, Dallas, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083885255 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | T1998 (Texas) | Secondary |
208000000X | Pediatrics | T1998 (Texas) | Secondary |
207LP3000X | Anesthesiology - Pediatric Anesthesiology | T1998 (Texas) | Primary |
Entity Name | Childrens Anesthesiology Associates Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689779480 PECOS PAC ID: 5799688529 Enrollment ID: O20040324000032 |
News Archive
Quick-Med Technologies, Inc. announced today that it has successfully completed its joint development program with Foster Corporation, a member of PolyMedex Discovery Group, to collaborate in applying Quick-Med's proprietary NIMBUS® technology to thermoplastics for catheters and other medical product applications.
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a potential new approach for treating urinary tract infections (UTIs) - which affect millions of people annually - without traditional antibiotics. Because it involves non-antibiotic compounds, the approach would not contribute to the growing problem of antibiotic-resistant bacteria, or "superbugs."
Athersys, Inc. and Angiotech Pharmaceuticals, Inc. announced that Athersys has completed patient enrollment for its phase I clinical trial of MultiStem(R), its allogeneic stem cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. Top line results of the trial are expected to be announced midyear, upon completion of the four-month patient follow-up visits and analysis of results.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Arul M Lingappan, MD 1935 Medical District Dr, Dallas, TX 75235-7701 Ph: (214) 456-6393 | Dr Arul M Lingappan, MD 1935 Medical District Dr, Dallas, TX 75235-7701 Ph: (214) 456-6393 |
News Archive
Quick-Med Technologies, Inc. announced today that it has successfully completed its joint development program with Foster Corporation, a member of PolyMedex Discovery Group, to collaborate in applying Quick-Med's proprietary NIMBUS® technology to thermoplastics for catheters and other medical product applications.
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a potential new approach for treating urinary tract infections (UTIs) - which affect millions of people annually - without traditional antibiotics. Because it involves non-antibiotic compounds, the approach would not contribute to the growing problem of antibiotic-resistant bacteria, or "superbugs."
Athersys, Inc. and Angiotech Pharmaceuticals, Inc. announced that Athersys has completed patient enrollment for its phase I clinical trial of MultiStem(R), its allogeneic stem cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. Top line results of the trial are expected to be announced midyear, upon completion of the four-month patient follow-up visits and analysis of results.
Christine Bolden – a 26 year old woman was already brain dead from aneurysms, but doctors at a western Michigan hospital kept her on a respirator for a month to allow for the development of babies who were born prematurely at 25 weeks.
› Verified 1 days ago
Lee M. Lunsford, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-8000 | |
Dr. Stephanie C Jones, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9374 | |
Dr. Alfredo Ruben Lopez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Phone: 972-715-5000 Fax: 972-715-9976 | |
Dr. Elvis Tsang, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12222 Merit Dr Ste 600, Dallas, TX 75251 Phone: 972-715-5000 Fax: 972-715-9976 | |
Dr. Christopher D Lecheminant, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6606 Lbj Fwy Ste 200, Dallas, TX 75240 Phone: 972-715-5000 | |
Dr. Mihir N Rane, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3625 N Hall St Ste 800, Dallas, TX 75219 Phone: 214-252-3500 | |
Lisa Gu, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-6400 |